Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Flex Ltd (FLEX) vs Medpace Holdings Inc (MEDP) Price & Performance

Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Flex Ltd vs Medpace Holdings Inc — how do they compare? Flex Ltd trades at $118.37 (market cap $42.40B), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: Flex Ltd is far larger — about 2.5× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 4 Days and Medpace Holdings Inc for 14 Days on average.

FLEXMEDP
Market Cap
$42.40B$16.82B
Volume
2,642,359223,093
Sector
TechnologyHealth
52-Week High
$162.07$630.19
52-Week Low
$54.51$393.42
Typical Hold Time
4 Days14 Days
Enterprise Value
$45.49B$16.44B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Flex Ltd

No Aura AI signal available yet.

Medpace Holdings Inc

Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.

MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLEX

No sentiment data available yet.

MEDP
100% Buy0% Sell
Avg holding period · 14 Days

Top news

Latest headlines on both assets

About Flex Ltd

Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.

Read more on FLEX →

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP →